Zurueck zur Suche

Reporte zur Charge U030161

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

12Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 2 IL 2 WV 1 NY 1 NC 1 TX 1 OH 1 VA 1 MD 1

VAERS 2623297

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U030161

schwer
Staat
WV
Alter
1,8
Geschlecht
F
Eingang
28.04.2023
Impfdatum
25.04.2023
Beginn
27.04.2023
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Confusional state Dyskinesia Erythema Eye movement disorder Pyrexia Seizure Swelling

Symptomtext

the night after receiving the vaccine red and swelling on right side. Develop a fever 99-100 the next day. Treated with Tylenol. Seizure 4/27/2023. Mother noticed that baby looks confused and the baby started jerking and eyes started rolling. EMS was called and directed to take her home. No ill contact at home. Spike fever again at 104.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
no
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2366197

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030161

mild
Staat
NY
Alter
4,0
Geschlecht
M
Eingang
12.07.2022
Impfdatum
11.07.2022
Beginn
11.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Rash Swelling face Urticaria

Symptomtext

rash, facial swelling , hives ,Benadryl was given at the office

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
sore throat negative strep culture 6/23/2022
Vorgeschichte
none
Andere Medikamente
melatonin
Allergien
none
Vorherige Impfungen
-

VAERS 2325614

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030161

mild
Staat
MI
Alter
25,0
Geschlecht
M
Eingang
21.06.2022
Impfdatum
07.06.2022
Beginn
18.06.2022
Tage bis Beginn
11,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Erythema Injection site pruritus Pruritus

Symptomtext

SATURDAY IN THE EVENING OF JUNE 18TH PATIENT NOTICED ITCHING ON THE BACK OF THE RIGHT SHOULDER. WITHIN NEXT 2 DAYS THEY ALSO CAME ON THE RIGHT BACK SIDE OF THE ARM HAS A POCK, AS WELL AS ON THE SIDE OF THE RIGHT WRIST, RIGHT ARM, CHEST, BACK AND BACK OF SHOULDER. SPOTS ARE ITCHY AND RED, LOOK LIKE A MOSQUITO BITE. CHILLS EXPERIENCED TWO DAYS AGO, TREATED WITH ADVIL.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
SHRIMP AND CRAB ALLERGY, RESULTS IN SWELLING AND ITCHING IN LIPS AND MOUTH, ANAPHYLAXIS.
Vorherige Impfungen
-

VAERS 2321915

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030161

mild
Staat
NC
Alter
1,0
Geschlecht
F
Eingang
16.06.2022
Impfdatum
19.05.2022
Beginn
14.06.2022
Tage bis Beginn
26,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blister Otitis media Rash Rash pruritic Rash vesicular Urticaria

Symptomtext

Rash developed, blisters on bilateral legs. Rash very itchy. Diagnosed as Varicella rash

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
otitis media and urticaria 6/10/22
Vorgeschichte
none
Andere Medikamente
Amoxicillin Triamcinolone ointment
Allergien
none
Vorherige Impfungen
-

VAERS 2260459

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030161

mild
Staat
TX
Alter
17,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pruritus Rash Respiratory tract congestion

Symptomtext

Minor presented with congestion, itching and rash to neck and arms 1-2 hours after administration of 1st series vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2694814

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030161

gering
Staat
-
Alter
1,3
Geschlecht
F
Eingang
12.10.2023
Impfdatum
11.10.2023
Beginn
11.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

Vaccine expired on 09/28/23 and was given to patient on 10/11/2023. Vaccine coordinator and medical director notified. Parent of child notified by medical director. No adverse signs or symptoms noted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2607825

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030161

gering
Staat
MI
Alter
-
Geschlecht
F
Eingang
01.04.2023
Impfdatum
29.03.2023
Beginn
29.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Needle issue Occupational exposure to product

Symptomtext

Nurse calling to report that a drop of VARIVAX went into her eye after administration to a patient; the hub of the needle popped against the patient.; Nurse calling to report that a drop of VARIVAX went into her eye after administration to a patient; This spontaneous report as received from a nurse and refers to a 49-year-old female patient. No information on medical history, current condition or concomitant medications was provided. On 29-MAR-2023 after administration of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U030161 and expiration date 28-SEP-2023 for prophylaxis (exact dose and route of administration were not provided). The vaccine was administered by the nurse and a drop of varicella virus vaccine live (oka/merck)(VARIVAX) went into her eye as the hub of the needle popped against the patient (occupational exposure to product, needle issue and accidental exposure to product).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2564843

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030161

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
21.01.2023
Impfdatum
-
Beginn
13.12.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event Product preparation error

Symptomtext

No additional AE reported; Pharmacist reports an expired dose of sterile diluent [U035268 11/9/2022] was used to reconstitute VARIVAX [U030161 9/28/2023] and it was administered to a patient on 13DEC2022. Caller confirmed sterile diluent was not involved in a temperature excur; Pharmacist reports an expired dose of sterile diluent [U035268 11/9/2022] was used to reconstitute VARIVAX [U030161 9/28/2023]; This spontaneous report has been received from a pharmacist and refers to a patient of unknown age and gender. There was no information regarding the patient's medical history, concurrent conditions and concomitant medications provided. On 13-DEC-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection, lot# U030161 confirmed to be valid with expiration date 28-SEP-2023 (exact dose, dose number, route of administration and anatomical location were not reported) for prophylaxis. The vaccine was reconstituted with an expired dose of sterile diluent, lot # U035268 confirmed to be valid with expiration date 09-NOV-2022 (exact dose was not reported) (expired product administered, product preparation error). The reporter confirmed that sterile diluent was not involved in a temperature excursion and was stored according to the recommended storage range until administration. There was no additional adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2477829

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030161

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
14.10.2022
Impfdatum
19.09.2022
Beginn
19.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Caller is a office manager calling to report a temperautre excursion for VARIVAX. Caller reports that one dose of VARIVAX was administered to the patient on 19SEP2022; This spontaneous report has been received from an office manager referring to a patient of unknown age and gender. The patient's pertinent concurrent conditions, medical history, drugs reactions or allergies and concomitant medications were not provided. On 19-SEP-2022, the patient was vaccinated with one dose of improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) lot number U030161 has been verified to be a valid lot number with expiration date on 28-SEP-2023, administered as prophylaxis (strength, dose, vaccination scheme, route of administration and anatomical location was not provided). The varicella virus vaccine live (Oka/Merck) (VARIVAX) was stored at a temperature of 75-degree Fahrenheit, for an unknown time frame (product storage error). There was no previous temperature excursion, but It was reported that the excursion was still ongoing. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2412971

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030161

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
17.08.2022
Impfdatum
06.07.2022
Beginn
06.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AEs or PQC reported; Caller reported VARIVAX was administered after temperature excursion.; This spontaneous report was received from an office manager referring to a patient of an unknown age and gender. The patient's pertinent medical history, concurrent conditions, drugs reactions or allergies and concomitant therapies was not provided. On 06-JUL-2022, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliters (ml) lot #U030161 has been verified to be a valid lot number with expiration date on 28-SEP-2023, administered subcutaneously (SQ) for prophylaxis (strength, vaccination scheme frequency and anatomical location were not provided). The administered vaccine experienced the temperature excursion of 41.5 degrees Fahrenheit (F) for a timeframe of frame 2 hours and 45 minutes. There was no previous temperature excursion. No adverse events (AEs) were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2410156

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030161

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
12.08.2022
Impfdatum
12.07.2022
Beginn
12.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse event; Caller reported VARIVAX was administered after temperature excursion.; This spontaneous report was received from an office manager concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 12-JUL-2022, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #U030161, expiration date: 28-SEP-2023, administered subcutaneously for prophylaxis (strength was not provided), after a temperature excursion of 2 hours and 45 minutes at a temperature of 41.5F (product storage error). No previous temperature excursions were reported. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2410154

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030161

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
12.08.2022
Impfdatum
25.07.2022
Beginn
25.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional adverse event; VARIVAX and MMRII administered after a TE; This spontaneous report has been received from a registered nurse, concerning a patient of unknown age and gender. The patient's medical history, concomitant medications, concurrent conditions, previous drug reactions and allergies were not provided. On 25-JUL-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) injection (lot number U030161 which has been verified to be valid, expiration date reported and validated as 28-SEP-2023) and measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (rHA) (M-M-R II) injection (lot number U028163 which has been verified to be valid, expiration date reported and validated as 09-SEP-2023); both administered as prophylaxis (doses, routes of administration and anatomical sites of injection were not reported). The administered dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) was stored at a temperature of - 10 degrees Celsius (C) up to 8 C, during an unspecified time frame; and 3.4 C, during a time frame of 10 hours. The administered dose of measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (rHA) (M-M-R II) was stored at a temperature of 23.8 C, during a time frame of 9 hours and 45 minutes (product storage error). There was no previous temperature excursion. No additional adverse events were reported in the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-